IHC PD-L1 CLONE SP263(VENTANA)*

No Patient preparation is needed

PD-L1 expression by immunohistochemistry (IHC) is used as a biomarker to select patients for Intra cranial bleeding (ICB), and remains the gold standard as a companion/complementary diagnostic for anti-PD-1/PD-L1 therapy given association with higher response rates